menu search

Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me

42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...

October 22, 2023, 10:01 am

Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me

42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...

October 22, 2023, 10:01 am

Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me

42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...

October 22, 2023, 10:01 am

Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me

42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...

October 22, 2023, 10:01 am

Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me

42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...

October 22, 2023, 10:01 am

Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me

42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...

October 22, 2023, 10:01 am

Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me

42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...

October 22, 2023, 10:01 am

Hookipa pharma presents additional preliminary phase 2 data on hb-200 in combination with pembrolizumab as first-line treatment in patients with hpv16+ head and neck cancers at european society for me

42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line set...

October 22, 2023, 10:01 am

A huge bank doubled down on nio stock. it sold intel, salesforce, and disney.

DNB Asset Management materially raised an investment in electric-vehicle maker NIO....

October 22, 2023, 8:00 am

Inside meta, debate over what's fair in suppressing comments in the palestinian territories

The Instagram and Facebook owner has been wrestling with how to best enforce its content rules in the m...

October 21, 2023, 12:54 pm

Fincen targets crypto mixers in fight against terrorist financing

The US Treasury Department's Financial Crimes Enforcement Network (FinCEN) has designated cryptocurrenc...

October 20, 2023, 5:56 pm

Salesforce: ai is the growth catalyst

CRM has consistently delivered strong revenue growth over the past decade, with revenue exceeding $30 billion annually and growing at more than 10%. T...

October 20, 2023, 4:41 pm

Asia gold-gold price jump slows demand as india gears up for festival

Physical gold dealers in India were forced to offer steeper discounts this week as a jump in domestic p...

October 20, 2023, 4:29 pm

Bitcoin-only events in europe: a perspective on the community

From the very first days of Bitcoin, the community was its key driving force. Even more: it was the onl...

October 20, 2023, 4:29 pm

Hacu announces eleven honorees to be recognized at 37th annual conference on hispanic higher education, oct. 28-30, 2023

SAN ANTONIO, Oct. 20, 2023 (GLOBE NEWSWIRE) — The Hispanic Association of Colleges and Universities has announced 11 honorees will be recognized for...

October 20, 2023, 3:15 pm

A low-tolerance rba won’t yet have seen enough to move

The main domestic data this week was the September labour force release. As colleague Westpac Economist...

October 20, 2023, 2:57 pm

Wolverine's (www) strategic growth efforts appear encouraging

Wolverine (WWW) has been progressing well on its strategic initiatives. The company also reinforces its...

October 20, 2023, 1:32 pm

Livecare’s member acquisition surges with in-house program

Venice, FL, USA, Oct. 20, 2023 (GLOBE NEWSWIRE) — LiveCare, Inc. (OTC:LVCE), a pioneering force in th...

October 20, 2023, 1:30 pm

Legalzoom layoffs 2023: what to know about the latest lz job cuts

California-based LegalZoom (NASDAQ: LZ ) may be having some problems. The company is downsizing its workforce<...

October 20, 2023, 12:59 pm

Weekly market recap (16-20 october)

MondayOver the weekend we got some tentative dialling back of threats from Iran and Hezbollah as an Iranian ambassador told a journalist that “Iran�...

October 20, 2023, 12:53 pm


Search within

Pages Search Results: